Summary

The global Lateral Flow Immunochromatographic Assay Testing market is projected to grow from US$ 9000 million in 2025 to US$ 13512 million by 2032, at a CAGR of 6.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Lateral flow immunochromatographic assay testing is an in vitro testing technology that combines specific antigen–antibody interactions with capillary flow through a membrane, typically supplied as test strips, cassettes, or midstream devices. A sample migrates laterally through the medium, reacts with labeled reagents, and generates a signal in the detection region that can be read visually or by a compatible instrument for qualitative, semi-quantitative, or quantitative analysis. Common labels include colloidal gold, latex microspheres, and fluorescent particles. Medical applications include infectious diseases, reproductive and pregnancy testing, cardiovascular and inflammatory biomarkers, tumor markers, and drug abuse testing. This market scope covers finished test consumables only.
Key Findings
Global lateral flow immunochromatographic assay consumable production in 2025 is 6 billion units, with an average ex-factory price of US$1.50 per test
Infectious disease screening, reproductive and pregnancy testing, chronic disease-related biomarker testing, and drug abuse testing are the principal sources of demand
Colloidal gold, latex microsphere, and fluorescent labeling are the main technology categories
Single-analyte and multiplex tests address different requirements, with qualitative, semi-quantitative, and quantitative results
Assay performance, batch consistency, ease of use, total costs, and distribution coverage are important competitive factors
Market Trends
Technology development centers on sensitivity, multiplex testing, quantitative reading, and ease of use. Fluorescent labels combined with compatible readers provide a route to quantitative testing, while multiplex formats deliver information on several targets within one device. Product development must balance sample preparation, testing time, interpretation, and manufacturing consistency rather than evaluating performance solely by label materials or analyte counts.
Market Dynamics
Drivers
Lateral flow assays offer relatively simple operation for point-of-care testing, community screening, and authorized home self-testing. Infectious diseases, reproductive and pregnancy testing, and other biomarker applications generate diverse demand. Limited equipment requirements allow some products to serve settings with restricted laboratory infrastructure. Requirements for speed, affordability, and accessibility give these products a defined role.
Restraints
Performance depends on target concentration, sample type, collection quality, cross-reactivity, and operating conditions. Intended uses and result interpretation vary across products, and some applications require laboratory confirmation. Quantitative formats generally require compatible readers. Price-sensitive procurement and competition among comparable products can also constrain manufacturer profitability.
Opportunities
Multiplex assays, quantitative products suitable for decentralized settings, and simplified workflows offer development opportunities. Application-specific test combinations, improved sample preparation, and user training can increase practical value. Manufacturers with reliable production, validated performance, and international market access capabilities can also pursue contract manufacturing and regional partnerships.
Challenges
Manufacturers must balance sensitivity, specificity, testing time, stability, and cost. Variations in antibodies, membranes, and labels can affect performance, requiring comprehensive material qualification and quality control. Multiplex products must accommodate different reaction requirements while limiting interpretation complexity. Demand fluctuations can also create capacity-utilization and inventory pressures.
Industry Chain Analysis
Upstream suppliers provide antigens, antibodies, labeling particles, nitrocellulose membranes, sample pads, conjugate pads, absorbent pads, plastic housings, buffers, and packaging, alongside dispensing, cutting, and assembly equipment. Midstream activities include assay development, conjugation, strip manufacturing, assembly, performance validation, and quality testing. Downstream users include healthcare facilities, laboratories, screening organizations, pharmacies, distributors, and consumers using authorized self-tests.
Value Chain Analysis
Value is concentrated in recognition reagents, assay design, sample preparation, signal reading, stability, and batch consistency. Manufacturers must reduce costs through process control and scalable production while maintaining reliable performance. Clinical evaluation, market authorization, distribution support, and compatible reader platforms also contribute commercial value. Consumable and instrument revenues should be calculated separately.
Segment Insights
By labeling technology, colloidal gold and latex microspheres can generate visible signals, while fluorescent products generally use instrument-based reading. Single-analyte tests address defined targets, whereas multiplex products provide information on several targets. Qualitative assays assess whether a target meets specified decision criteria, semi-quantitative assays provide graded information, and quantitative assays require appropriate calibration and performance validation.
Downstream Market Opportunities
Infectious disease analysis should distinguish pathogens and antigen versus antibody applications. Reproductive and pregnancy testing requires consideration of home and professional channels. Cardiovascular and inflammatory biomarkers offer opportunities linked to point-of-care workflows and quantitative requirements. Tumor marker and drug abuse testing should be evaluated against specific intended uses; demand cannot be inferred simply from the number of available analytes.
Regional Insights
Regional comparisons should examine healthcare structures, point-of-care adoption, self-test authorization, and payment arrangements. Chinese market research can distinguish hospital, primary-care, and retail self-testing requirements and assess local suppliers through performance, costs, and delivery capabilities. Other markets require analysis of procurement systems, distribution networks, and registration requirements rather than extrapolation from a single region.
Competitive Landscape
Participants include diversified in vitro diagnostics companies, point-of-care specialists, and regional rapid-test manufacturers. Competition centers on testing menus, validated performance, quality consistency, pricing, market authorization, and distribution support. Company comparisons should separate test consumables, readers, and other technology platforms, while accounting for contract manufacturing relationships to avoid double counting market revenue.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Lateral Flow Immunochromatographic Assay Testing market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Abbott
Roche
QuidelOrtho
Wondfo Biotech
Getein Biotech
SD Biosensor
Orient Gene
ReLIA Biotech
ACON Biotech
Intec PRODUCT
Equinox Biotech Co
Shanghai Kehua Bio-engineering Co
Biotest Biotech
Assure Tech
Core Technology Co
Chongqing Zhongyuan BIO-TECHNOLOGY Co
Life Origin Biotech
Biotime
Anhui DEEPBLUE Medical Technology Co
Wantai BioPharm
Joinstar Biomedical Technology Co
J.H.Bio-Tec
Hangzhou Clongene Biotech Co
BIOHIT Healthcare
Nanjing Vazyme Biotech Co
Shenzhen GLD Biotechnology Co
Hunan beixier Biotechnology Co
Shandong Kanghua Biotechnology Co
BOSON BIOTECH
AVE Science & Technology Co
Segment by Type
Immunocolloidal Gold Technology
Immunofluorescence Technology
Segment by Number of Analytes per Test
Single-Analyte Testing
Multiplex Testing
Segment by Result Type
Qualitative Testing
Semi-Quantitative Testing
Quantitative Testing
Segment by Application
Cardiovascular Testing
Infectious Disease Testing
Drug Abuse Testing
Pregnancy Testing
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Lateral Flow Immunochromatographic Assay Testing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Lateral Flow Immunochromatographic Assay Testing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Lateral Flow Immunochromatographic Assay Testing Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Immunocolloidal Gold Technology
1.2.3 Immunofluorescence Technology
1.3 Market Segmentation by Number of Analytes per Test
1.3.1 Global Lateral Flow Immunochromatographic Assay Testing Market Size by Number of Analytes per Test, 2021 vs 2025 vs 2032
1.3.2 Single-Analyte Testing
1.3.3 Multiplex Testing
1.4 Market Segmentation by Result Type
1.4.1 Global Lateral Flow Immunochromatographic Assay Testing Market Size by Result Type, 2021 vs 2025 vs 2032
1.4.2 Qualitative Testing
1.4.3 Semi-Quantitative Testing
1.4.4 Quantitative Testing
1.5 Market Segmentation by Application
1.5.1 Global Lateral Flow Immunochromatographic Assay Testing Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Cardiovascular Testing
1.5.3 Infectious Disease Testing
1.5.4 Drug Abuse Testing
1.5.5 Pregnancy Testing
1.5.6 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Lateral Flow Immunochromatographic Assay Testing Revenue Estimates and Forecasts (2021-2032)
2.2 Global Lateral Flow Immunochromatographic Assay Testing Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Lateral Flow Immunochromatographic Assay Testing Sales Estimates and Forecasts (2021-2032)
2.4 Global Lateral Flow Immunochromatographic Assay Testing Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Lateral Flow Immunochromatographic Assay Testing Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Lateral Flow Immunochromatographic Assay Testing Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Immunocolloidal Gold Technology: Market Share by Key Manufacturers
3.5.2 Immunofluorescence Technology: Market Share by Key Manufacturers
3.6 Global Lateral Flow Immunochromatographic Assay Testing Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Lateral Flow Immunochromatographic Assay Testing Sales Performance by Type
4.1.1 Global Lateral Flow Immunochromatographic Assay Testing Sales Volume by Type (2021-2032)
4.1.2 Global Lateral Flow Immunochromatographic Assay Testing Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Lateral Flow Immunochromatographic Assay Testing Sales Performance by Number of Analytes per Test
4.2.1 Global Lateral Flow Immunochromatographic Assay Testing Sales Volume by Number of Analytes per Test (2021-2032)
4.2.2 Global Lateral Flow Immunochromatographic Assay Testing Revenue by Number of Analytes per Test (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Number of Analytes per Test (2021-2032)
4.3 Global Lateral Flow Immunochromatographic Assay Testing Sales Performance by Result Type
4.3.1 Global Lateral Flow Immunochromatographic Assay Testing Sales Volume by Result Type (2021-2032)
4.3.2 Global Lateral Flow Immunochromatographic Assay Testing Revenue by Result Type (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Result Type (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Lateral Flow Immunochromatographic Assay Testing Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Lateral Flow Immunochromatographic Assay Testing Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Lateral Flow Immunochromatographic Assay Testing Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Lateral Flow Immunochromatographic Assay Testing Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Lateral Flow Immunochromatographic Assay Testing Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Lateral Flow Immunochromatographic Assay Testing Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Lateral Flow Immunochromatographic Assay Testing Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Lateral Flow Immunochromatographic Assay Testing Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Lateral Flow Immunochromatographic Assay Testing Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Lateral Flow Immunochromatographic Assay Testing Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Lateral Flow Immunochromatographic Assay Testing Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Lateral Flow Immunochromatographic Assay Testing Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.1.4 Abbott Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Abbott Lateral Flow Immunochromatographic Assay Testing Sales by Product in 2025
11.1.6 Abbott Lateral Flow Immunochromatographic Assay Testing Sales by Application in 2025
11.1.7 Abbott Lateral Flow Immunochromatographic Assay Testing Sales by Geographic Area in 2025
11.1.8 Abbott Lateral Flow Immunochromatographic Assay Testing SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Business Overview
11.2.3 Roche Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.2.4 Roche Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Roche Lateral Flow Immunochromatographic Assay Testing Sales by Product in 2025
11.2.6 Roche Lateral Flow Immunochromatographic Assay Testing Sales by Application in 2025
11.2.7 Roche Lateral Flow Immunochromatographic Assay Testing Sales by Geographic Area in 2025
11.2.8 Roche Lateral Flow Immunochromatographic Assay Testing SWOT Analysis
11.2.9 Roche Recent Developments
11.3 QuidelOrtho
11.3.1 QuidelOrtho Corporation Information
11.3.2 QuidelOrtho Business Overview
11.3.3 QuidelOrtho Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.3.4 QuidelOrtho Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 QuidelOrtho Lateral Flow Immunochromatographic Assay Testing Sales by Product in 2025
11.3.6 QuidelOrtho Lateral Flow Immunochromatographic Assay Testing Sales by Application in 2025
11.3.7 QuidelOrtho Lateral Flow Immunochromatographic Assay Testing Sales by Geographic Area in 2025
11.3.8 QuidelOrtho Lateral Flow Immunochromatographic Assay Testing SWOT Analysis
11.3.9 QuidelOrtho Recent Developments
11.4 Wondfo Biotech
11.4.1 Wondfo Biotech Corporation Information
11.4.2 Wondfo Biotech Business Overview
11.4.3 Wondfo Biotech Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.4.4 Wondfo Biotech Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Wondfo Biotech Lateral Flow Immunochromatographic Assay Testing Sales by Product in 2025
11.4.6 Wondfo Biotech Lateral Flow Immunochromatographic Assay Testing Sales by Application in 2025
11.4.7 Wondfo Biotech Lateral Flow Immunochromatographic Assay Testing Sales by Geographic Area in 2025
11.4.8 Wondfo Biotech Lateral Flow Immunochromatographic Assay Testing SWOT Analysis
11.4.9 Wondfo Biotech Recent Developments
11.5 Getein Biotech
11.5.1 Getein Biotech Corporation Information
11.5.2 Getein Biotech Business Overview
11.5.3 Getein Biotech Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.5.4 Getein Biotech Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Getein Biotech Lateral Flow Immunochromatographic Assay Testing Sales by Product in 2025
11.5.6 Getein Biotech Lateral Flow Immunochromatographic Assay Testing Sales by Application in 2025
11.5.7 Getein Biotech Lateral Flow Immunochromatographic Assay Testing Sales by Geographic Area in 2025
11.5.8 Getein Biotech Lateral Flow Immunochromatographic Assay Testing SWOT Analysis
11.5.9 Getein Biotech Recent Developments
11.6 SD Biosensor
11.6.1 SD Biosensor Corporation Information
11.6.2 SD Biosensor Business Overview
11.6.3 SD Biosensor Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.6.4 SD Biosensor Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 SD Biosensor Recent Developments
11.7 Orient Gene
11.7.1 Orient Gene Corporation Information
11.7.2 Orient Gene Business Overview
11.7.3 Orient Gene Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.7.4 Orient Gene Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Orient Gene Recent Developments
11.8 ReLIA Biotech
11.8.1 ReLIA Biotech Corporation Information
11.8.2 ReLIA Biotech Business Overview
11.8.3 ReLIA Biotech Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.8.4 ReLIA Biotech Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 ReLIA Biotech Recent Developments
11.9 ACON Biotech
11.9.1 ACON Biotech Corporation Information
11.9.2 ACON Biotech Business Overview
11.9.3 ACON Biotech Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.9.4 ACON Biotech Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 ACON Biotech Recent Developments
11.10 Intec PRODUCT
11.10.1 Intec PRODUCT Corporation Information
11.10.2 Intec PRODUCT Business Overview
11.10.3 Intec PRODUCT Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.10.4 Intec PRODUCT Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Intec PRODUCT Recent Developments
11.11 Equinox Biotech Co
11.11.1 Equinox Biotech Co Corporation Information
11.11.2 Equinox Biotech Co Business Overview
11.11.3 Equinox Biotech Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.11.4 Equinox Biotech Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Equinox Biotech Co Recent Developments
11.12 Shanghai Kehua Bio-engineering Co
11.12.1 Shanghai Kehua Bio-engineering Co Corporation Information
11.12.2 Shanghai Kehua Bio-engineering Co Business Overview
11.12.3 Shanghai Kehua Bio-engineering Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.12.4 Shanghai Kehua Bio-engineering Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Shanghai Kehua Bio-engineering Co Recent Developments
11.13 Biotest Biotech
11.13.1 Biotest Biotech Corporation Information
11.13.2 Biotest Biotech Business Overview
11.13.3 Biotest Biotech Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.13.4 Biotest Biotech Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Biotest Biotech Recent Developments
11.14 Assure Tech
11.14.1 Assure Tech Corporation Information
11.14.2 Assure Tech Business Overview
11.14.3 Assure Tech Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.14.4 Assure Tech Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Assure Tech Recent Developments
11.15 Core Technology Co
11.15.1 Core Technology Co Corporation Information
11.15.2 Core Technology Co Business Overview
11.15.3 Core Technology Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.15.4 Core Technology Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Core Technology Co Recent Developments
11.16 Chongqing Zhongyuan BIO-TECHNOLOGY Co
11.16.1 Chongqing Zhongyuan BIO-TECHNOLOGY Co Corporation Information
11.16.2 Chongqing Zhongyuan BIO-TECHNOLOGY Co Business Overview
11.16.3 Chongqing Zhongyuan BIO-TECHNOLOGY Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.16.4 Chongqing Zhongyuan BIO-TECHNOLOGY Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Chongqing Zhongyuan BIO-TECHNOLOGY Co Recent Developments
11.17 Life Origin Biotech
11.17.1 Life Origin Biotech Corporation Information
11.17.2 Life Origin Biotech Business Overview
11.17.3 Life Origin Biotech Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.17.4 Life Origin Biotech Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Life Origin Biotech Recent Developments
11.18 Biotime
11.18.1 Biotime Corporation Information
11.18.2 Biotime Business Overview
11.18.3 Biotime Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.18.4 Biotime Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Biotime Recent Developments
11.19 Anhui DEEPBLUE Medical Technology Co
11.19.1 Anhui DEEPBLUE Medical Technology Co Corporation Information
11.19.2 Anhui DEEPBLUE Medical Technology Co Business Overview
11.19.3 Anhui DEEPBLUE Medical Technology Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.19.4 Anhui DEEPBLUE Medical Technology Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Anhui DEEPBLUE Medical Technology Co Recent Developments
11.20 Wantai BioPharm
11.20.1 Wantai BioPharm Corporation Information
11.20.2 Wantai BioPharm Business Overview
11.20.3 Wantai BioPharm Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.20.4 Wantai BioPharm Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 Wantai BioPharm Recent Developments
11.21 Joinstar Biomedical Technology Co
11.21.1 Joinstar Biomedical Technology Co Corporation Information
11.21.2 Joinstar Biomedical Technology Co Business Overview
11.21.3 Joinstar Biomedical Technology Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.21.4 Joinstar Biomedical Technology Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 Joinstar Biomedical Technology Co Recent Developments
11.22 J.H.Bio-Tec
11.22.1 J.H.Bio-Tec Corporation Information
11.22.2 J.H.Bio-Tec Business Overview
11.22.3 J.H.Bio-Tec Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.22.4 J.H.Bio-Tec Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 J.H.Bio-Tec Recent Developments
11.23 Hangzhou Clongene Biotech Co
11.23.1 Hangzhou Clongene Biotech Co Corporation Information
11.23.2 Hangzhou Clongene Biotech Co Business Overview
11.23.3 Hangzhou Clongene Biotech Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.23.4 Hangzhou Clongene Biotech Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.23.5 Hangzhou Clongene Biotech Co Recent Developments
11.24 BIOHIT Healthcare
11.24.1 BIOHIT Healthcare Corporation Information
11.24.2 BIOHIT Healthcare Business Overview
11.24.3 BIOHIT Healthcare Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.24.4 BIOHIT Healthcare Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.24.5 BIOHIT Healthcare Recent Developments
11.25 Nanjing Vazyme Biotech Co
11.25.1 Nanjing Vazyme Biotech Co Corporation Information
11.25.2 Nanjing Vazyme Biotech Co Business Overview
11.25.3 Nanjing Vazyme Biotech Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.25.4 Nanjing Vazyme Biotech Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.25.5 Nanjing Vazyme Biotech Co Recent Developments
11.26 Shenzhen GLD Biotechnology Co
11.26.1 Shenzhen GLD Biotechnology Co Corporation Information
11.26.2 Shenzhen GLD Biotechnology Co Business Overview
11.26.3 Shenzhen GLD Biotechnology Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.26.4 Shenzhen GLD Biotechnology Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.26.5 Shenzhen GLD Biotechnology Co Recent Developments
11.27 Hunan beixier Biotechnology Co
11.27.1 Hunan beixier Biotechnology Co Corporation Information
11.27.2 Hunan beixier Biotechnology Co Business Overview
11.27.3 Hunan beixier Biotechnology Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.27.4 Hunan beixier Biotechnology Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.27.5 Hunan beixier Biotechnology Co Recent Developments
11.28 Shandong Kanghua Biotechnology Co
11.28.1 Shandong Kanghua Biotechnology Co Corporation Information
11.28.2 Shandong Kanghua Biotechnology Co Business Overview
11.28.3 Shandong Kanghua Biotechnology Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.28.4 Shandong Kanghua Biotechnology Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.28.5 Shandong Kanghua Biotechnology Co Recent Developments
11.29 BOSON BIOTECH
11.29.1 BOSON BIOTECH Corporation Information
11.29.2 BOSON BIOTECH Business Overview
11.29.3 BOSON BIOTECH Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.29.4 BOSON BIOTECH Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.29.5 BOSON BIOTECH Recent Developments
11.30 AVE Science & Technology Co
11.30.1 AVE Science & Technology Co Corporation Information
11.30.2 AVE Science & Technology Co Business Overview
11.30.3 AVE Science & Technology Co Lateral Flow Immunochromatographic Assay Testing Product Models, Descriptions and Specifications
11.30.4 AVE Science & Technology Co Lateral Flow Immunochromatographic Assay Testing Sales, Price, Revenue and Gross Margin (2021-2026)
11.30.5 AVE Science & Technology Co Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Lateral Flow Immunochromatographic Assay Testing Industry Chain
12.2 Lateral Flow Immunochromatographic Assay Testing Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Lateral Flow Immunochromatographic Assay Testing Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Lateral Flow Immunochromatographic Assay Testing Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Lateral Flow Immunochromatographic Assay Testing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Lateral Flow Immunochromatographic Assay Testing Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Lateral Flow Immunochromatographic Assay Testing Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Lateral Flow Immunochromatographic Assay Testing Market Size Growth Rate by Number of Analytes per Test, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Lateral Flow Immunochromatographic Assay Testing Market Size Growth Rate by Result Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Lateral Flow Immunochromatographic Assay Testing Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Lateral Flow Immunochromatographic Assay Testing Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Lateral Flow Immunochromatographic Assay Testing Revenue by Region (US$ Million), 2021-2026
Table 7. Global Lateral Flow Immunochromatographic Assay Testing Revenue by Region (US$ Million), 2027-2032
Table 8. Global Lateral Flow Immunochromatographic Assay Testing Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global Lateral Flow Immunochromatographic Assay Testing Sales by Region (K Units), 2021-2026
Table 10. Global Lateral Flow Immunochromatographic Assay Testing Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Lateral Flow Immunochromatographic Assay Testing Sales by Manufacturers (K Units), 2021-2026
Table 13. Global Lateral Flow Immunochromatographic Assay Testing Sales Share by Manufacturers (2021-2026)
Table 14. Global Lateral Flow Immunochromatographic Assay Testing Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Lateral Flow Immunochromatographic Assay Testing Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Lateral Flow Immunochromatographic Assay Testing Revenue, 2025
Table 18. Global Lateral Flow Immunochromatographic Assay Testing Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Lateral Flow Immunochromatographic Assay Testing Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 20. Key Manufacturers Lateral Flow Immunochromatographic Assay Testing Manufacturing Base and Headquarters
Table 21. Global Lateral Flow Immunochromatographic Assay Testing Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Lateral Flow Immunochromatographic Assay Testing Sales Volume by Type (K Units), 2021-2026
Table 25. Global Lateral Flow Immunochromatographic Assay Testing Sales Volume by Type (K Units), 2027-2032
Table 26. Global Lateral Flow Immunochromatographic Assay Testing Revenue by Type (US$ Million), 2021-2026
Table 27. Global Lateral Flow Immunochromatographic Assay Testing Revenue by Type (US$ Million), 2027-2032
Table 28. Global Lateral Flow Immunochromatographic Assay Testing Sales Volume by Number of Analytes per Test (K Units), 2021-2026
Table 29. Global Lateral Flow Immunochromatographic Assay Testing Sales Volume by Number of Analytes per Test (K Units), 2027-2032
Table 30. Global Lateral Flow Immunochromatographic Assay Testing Revenue by Number of Analytes per Test (US$ Million), 2021-2026
Table 31. Global Lateral Flow Immunochromatographic Assay Testing Revenue by Number of Analytes per Test (US$ Million), 2027-2032
Table 32. Global Lateral Flow Immunochromatographic Assay Testing Sales Volume by Result Type (K Units), 2021-2026
Table 33. Global Lateral Flow Immunochromatographic Assay Testing Sales Volume by Result Type (K Units), 2027-2032
Table 34. Global Lateral Flow Immunochromatographic Assay Testing Revenue by Result Type (US$ Million), 2021-2026
Table 35. Global Lateral Flow Immunochromatographic Assay Testing Revenue by Result Type (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Lateral Flow Immunochromatographic Assay Testing Sales by Application (K Units), 2021-2026
Table 38. Global Lateral Flow Immunochromatographic Assay Testing Sales by Application (K Units), 2027-2032
Table 39. Lateral Flow Immunochromatographic Assay Testing High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Lateral Flow Immunochromatographic Assay Testing Revenue by Application (US$ Million), 2021-2026
Table 41. Global Lateral Flow Immunochromatographic Assay Testing Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Lateral Flow Immunochromatographic Assay Testing Growth Accelerators and Market Barriers
Table 45. North America Lateral Flow Immunochromatographic Assay Testing Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Lateral Flow Immunochromatographic Assay Testing Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Lateral Flow Immunochromatographic Assay Testing Growth Accelerators and Market Barriers
Table 48. Europe Lateral Flow Immunochromatographic Assay Testing Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Lateral Flow Immunochromatographic Assay Testing Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Lateral Flow Immunochromatographic Assay Testing Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Lateral Flow Immunochromatographic Assay Testing Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Lateral Flow Immunochromatographic Assay Testing Growth Accelerators and Market Barriers
Table 53. Southeast Asia Lateral Flow Immunochromatographic Assay Testing Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Lateral Flow Immunochromatographic Assay Testing Investment Opportunities and Key Challenges
Table 55. Central and South America Lateral Flow Immunochromatographic Assay Testing Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Lateral Flow Immunochromatographic Assay Testing Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Lateral Flow Immunochromatographic Assay Testing Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Abbott Corporation Information
Table 59. Abbott Description and Major Businesses
Table 60. Abbott Product Models, Descriptions and Specifications
Table 61. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 62. Abbott Sales Value Proportion by Product in 2025
Table 63. Abbott Sales Value Proportion by Application in 2025
Table 64. Abbott Sales Value Proportion by Geographic Area in 2025
Table 65. Abbott Lateral Flow Immunochromatographic Assay Testing SWOT Analysis
Table 66. Abbott Recent Developments
Table 67. Roche Corporation Information
Table 68. Roche Description and Major Businesses
Table 69. Roche Product Models, Descriptions and Specifications
Table 70. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Roche Sales Value Proportion by Product in 2025
Table 72. Roche Sales Value Proportion by Application in 2025
Table 73. Roche Sales Value Proportion by Geographic Area in 2025
Table 74. Roche Lateral Flow Immunochromatographic Assay Testing SWOT Analysis
Table 75. Roche Recent Developments
Table 76. QuidelOrtho Corporation Information
Table 77. QuidelOrtho Description and Major Businesses
Table 78. QuidelOrtho Product Models, Descriptions and Specifications
Table 79. QuidelOrtho Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. QuidelOrtho Sales Value Proportion by Product in 2025
Table 81. QuidelOrtho Sales Value Proportion by Application in 2025
Table 82. QuidelOrtho Sales Value Proportion by Geographic Area in 2025
Table 83. QuidelOrtho Lateral Flow Immunochromatographic Assay Testing SWOT Analysis
Table 84. QuidelOrtho Recent Developments
Table 85. Wondfo Biotech Corporation Information
Table 86. Wondfo Biotech Description and Major Businesses
Table 87. Wondfo Biotech Product Models, Descriptions and Specifications
Table 88. Wondfo Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Wondfo Biotech Sales Value Proportion by Product in 2025
Table 90. Wondfo Biotech Sales Value Proportion by Application in 2025
Table 91. Wondfo Biotech Sales Value Proportion by Geographic Area in 2025
Table 92. Wondfo Biotech Lateral Flow Immunochromatographic Assay Testing SWOT Analysis
Table 93. Wondfo Biotech Recent Developments
Table 94. Getein Biotech Corporation Information
Table 95. Getein Biotech Description and Major Businesses
Table 96. Getein Biotech Product Models, Descriptions and Specifications
Table 97. Getein Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Getein Biotech Sales Value Proportion by Product in 2025
Table 99. Getein Biotech Sales Value Proportion by Application in 2025
Table 100. Getein Biotech Sales Value Proportion by Geographic Area in 2025
Table 101. Getein Biotech Lateral Flow Immunochromatographic Assay Testing SWOT Analysis
Table 102. Getein Biotech Recent Developments
Table 103. SD Biosensor Corporation Information
Table 104. SD Biosensor Description and Major Businesses
Table 105. SD Biosensor Product Models, Descriptions and Specifications
Table 106. SD Biosensor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. SD Biosensor Recent Developments
Table 108. Orient Gene Corporation Information
Table 109. Orient Gene Description and Major Businesses
Table 110. Orient Gene Product Models, Descriptions and Specifications
Table 111. Orient Gene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Orient Gene Recent Developments
Table 113. ReLIA Biotech Corporation Information
Table 114. ReLIA Biotech Description and Major Businesses
Table 115. ReLIA Biotech Product Models, Descriptions and Specifications
Table 116. ReLIA Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. ReLIA Biotech Recent Developments
Table 118. ACON Biotech Corporation Information
Table 119. ACON Biotech Description and Major Businesses
Table 120. ACON Biotech Product Models, Descriptions and Specifications
Table 121. ACON Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. ACON Biotech Recent Developments
Table 123. Intec PRODUCT Corporation Information
Table 124. Intec PRODUCT Description and Major Businesses
Table 125. Intec PRODUCT Product Models, Descriptions and Specifications
Table 126. Intec PRODUCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Intec PRODUCT Recent Developments
Table 128. Equinox Biotech Co Corporation Information
Table 129. Equinox Biotech Co Description and Major Businesses
Table 130. Equinox Biotech Co Product Models, Descriptions and Specifications
Table 131. Equinox Biotech Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Equinox Biotech Co Recent Developments
Table 133. Shanghai Kehua Bio-engineering Co Corporation Information
Table 134. Shanghai Kehua Bio-engineering Co Description and Major Businesses
Table 135. Shanghai Kehua Bio-engineering Co Product Models, Descriptions and Specifications
Table 136. Shanghai Kehua Bio-engineering Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Shanghai Kehua Bio-engineering Co Recent Developments
Table 138. Biotest Biotech Corporation Information
Table 139. Biotest Biotech Description and Major Businesses
Table 140. Biotest Biotech Product Models, Descriptions and Specifications
Table 141. Biotest Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Biotest Biotech Recent Developments
Table 143. Assure Tech Corporation Information
Table 144. Assure Tech Description and Major Businesses
Table 145. Assure Tech Product Models, Descriptions and Specifications
Table 146. Assure Tech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Assure Tech Recent Developments
Table 148. Core Technology Co Corporation Information
Table 149. Core Technology Co Description and Major Businesses
Table 150. Core Technology Co Product Models, Descriptions and Specifications
Table 151. Core Technology Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Core Technology Co Recent Developments
Table 153. Chongqing Zhongyuan BIO-TECHNOLOGY Co Corporation Information
Table 154. Chongqing Zhongyuan BIO-TECHNOLOGY Co Description and Major Businesses
Table 155. Chongqing Zhongyuan BIO-TECHNOLOGY Co Product Models, Descriptions and Specifications
Table 156. Chongqing Zhongyuan BIO-TECHNOLOGY Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Chongqing Zhongyuan BIO-TECHNOLOGY Co Recent Developments
Table 158. Life Origin Biotech Corporation Information
Table 159. Life Origin Biotech Description and Major Businesses
Table 160. Life Origin Biotech Product Models, Descriptions and Specifications
Table 161. Life Origin Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Life Origin Biotech Recent Developments
Table 163. Biotime Corporation Information
Table 164. Biotime Description and Major Businesses
Table 165. Biotime Product Models, Descriptions and Specifications
Table 166. Biotime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Biotime Recent Developments
Table 168. Anhui DEEPBLUE Medical Technology Co Corporation Information
Table 169. Anhui DEEPBLUE Medical Technology Co Description and Major Businesses
Table 170. Anhui DEEPBLUE Medical Technology Co Product Models, Descriptions and Specifications
Table 171. Anhui DEEPBLUE Medical Technology Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Anhui DEEPBLUE Medical Technology Co Recent Developments
Table 173. Wantai BioPharm Corporation Information
Table 174. Wantai BioPharm Description and Major Businesses
Table 175. Wantai BioPharm Product Models, Descriptions and Specifications
Table 176. Wantai BioPharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. Wantai BioPharm Recent Developments
Table 178. Joinstar Biomedical Technology Co Corporation Information
Table 179. Joinstar Biomedical Technology Co Description and Major Businesses
Table 180. Joinstar Biomedical Technology Co Product Models, Descriptions and Specifications
Table 181. Joinstar Biomedical Technology Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. Joinstar Biomedical Technology Co Recent Developments
Table 183. J.H.Bio-Tec Corporation Information
Table 184. J.H.Bio-Tec Description and Major Businesses
Table 185. J.H.Bio-Tec Product Models, Descriptions and Specifications
Table 186. J.H.Bio-Tec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. J.H.Bio-Tec Recent Developments
Table 188. Hangzhou Clongene Biotech Co Corporation Information
Table 189. Hangzhou Clongene Biotech Co Description and Major Businesses
Table 190. Hangzhou Clongene Biotech Co Product Models, Descriptions and Specifications
Table 191. Hangzhou Clongene Biotech Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 192. Hangzhou Clongene Biotech Co Recent Developments
Table 193. BIOHIT Healthcare Corporation Information
Table 194. BIOHIT Healthcare Description and Major Businesses
Table 195. BIOHIT Healthcare Product Models, Descriptions and Specifications
Table 196. BIOHIT Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 197. BIOHIT Healthcare Recent Developments
Table 198. Nanjing Vazyme Biotech Co Corporation Information
Table 199. Nanjing Vazyme Biotech Co Description and Major Businesses
Table 200. Nanjing Vazyme Biotech Co Product Models, Descriptions and Specifications
Table 201. Nanjing Vazyme Biotech Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 202. Nanjing Vazyme Biotech Co Recent Developments
Table 203. Shenzhen GLD Biotechnology Co Corporation Information
Table 204. Shenzhen GLD Biotechnology Co Description and Major Businesses
Table 205. Shenzhen GLD Biotechnology Co Product Models, Descriptions and Specifications
Table 206. Shenzhen GLD Biotechnology Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 207. Shenzhen GLD Biotechnology Co Recent Developments
Table 208. Hunan beixier Biotechnology Co Corporation Information
Table 209. Hunan beixier Biotechnology Co Description and Major Businesses
Table 210. Hunan beixier Biotechnology Co Product Models, Descriptions and Specifications
Table 211. Hunan beixier Biotechnology Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 212. Hunan beixier Biotechnology Co Recent Developments
Table 213. Shandong Kanghua Biotechnology Co Corporation Information
Table 214. Shandong Kanghua Biotechnology Co Description and Major Businesses
Table 215. Shandong Kanghua Biotechnology Co Product Models, Descriptions and Specifications
Table 216. Shandong Kanghua Biotechnology Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 217. Shandong Kanghua Biotechnology Co Recent Developments
Table 218. BOSON BIOTECH Corporation Information
Table 219. BOSON BIOTECH Description and Major Businesses
Table 220. BOSON BIOTECH Product Models, Descriptions and Specifications
Table 221. BOSON BIOTECH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 222. BOSON BIOTECH Recent Developments
Table 223. AVE Science & Technology Co Corporation Information
Table 224. AVE Science & Technology Co Description and Major Businesses
Table 225. AVE Science & Technology Co Product Models, Descriptions and Specifications
Table 226. AVE Science & Technology Co Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 227. AVE Science & Technology Co Recent Developments
Table 228. Key Raw Materials Distribution
Table 229. Raw Materials Key Suppliers
Table 230. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 231. Milestones in Production Technology Evolution
Table 232. Distributors List
Table 233. Market Trends and Market Evolution
Table 234. Market Drivers and Opportunities
Table 235. Market Challenges, Risks, and Restraints
Table 236. Research Programs/Design for This Report
Table 237. Key Data Information from Secondary Sources
Table 238. Key Data Information from Primary Sources

List of Figures
Figure 1. Lateral Flow Immunochromatographic Assay Testing Product Picture
Figure 2. Global Lateral Flow Immunochromatographic Assay Testing Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Immunocolloidal Gold Technology Product Picture
Figure 4. Immunofluorescence Technology Product Picture
Figure 5. Global Lateral Flow Immunochromatographic Assay Testing Market Size Growth Rate by Number of Analytes per Test, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Single-Analyte Testing Product Picture
Figure 7. Multiplex Testing Product Picture
Figure 8. Global Lateral Flow Immunochromatographic Assay Testing Market Size Growth Rate by Result Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 9. Qualitative Testing Product Picture
Figure 10. Semi-Quantitative Testing Product Picture
Figure 11. Quantitative Testing Product Picture
Figure 12. Global Lateral Flow Immunochromatographic Assay Testing Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 13. Cardiovascular Testing
Figure 14. Infectious Disease Testing
Figure 15. Drug Abuse Testing
Figure 16. Pregnancy Testing
Figure 17. Other
Figure 18. Lateral Flow Immunochromatographic Assay Testing Report Years Considered
Figure 19. Global Lateral Flow Immunochromatographic Assay Testing Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 21. Global Lateral Flow Immunochromatographic Assay Testing Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 22. Global Lateral Flow Immunochromatographic Assay Testing Revenue-Based Market Share by Region (2021-2032)
Figure 23. Global Lateral Flow Immunochromatographic Assay Testing Sales (K Units), 2021-2032
Figure 24. Global Lateral Flow Immunochromatographic Assay Testing Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 25. Global Lateral Flow Immunochromatographic Assay Testing Sales Market Share by Region (2021-2032)
Figure 26. Top 5 and Top 10 Manufacturers Lateral Flow Immunochromatographic Assay Testing Sales Volume Market Share in 2025
Figure 27. Global Lateral Flow Immunochromatographic Assay Testing Revenue-Based Market Share Ranking (2025)
Figure 28. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 29. Immunocolloidal Gold Technology Revenue-Based Market Share by Manufacturer in 2025
Figure 30. Immunofluorescence Technology Revenue-Based Market Share by Manufacturer in 2025
Figure 31. Global Lateral Flow Immunochromatographic Assay Testing Sales Volume-Based Market Share by Type (2021-2032)
Figure 32. Global Lateral Flow Immunochromatographic Assay Testing Revenue-Based Market Share by Type (2021-2032)
Figure 33. Global Lateral Flow Immunochromatographic Assay Testing ASP by Type (US$/Unit), 2021-2032
Figure 34. Global Lateral Flow Immunochromatographic Assay Testing Sales Volume-Based Market Share by Number of Analytes per Test (2021-2032)
Figure 35. Global Lateral Flow Immunochromatographic Assay Testing Revenue-Based Market Share by Number of Analytes per Test (2021-2032)
Figure 36. Global Lateral Flow Immunochromatographic Assay Testing ASP by Number of Analytes per Test (US$/Unit), 2021-2032
Figure 37. Global Lateral Flow Immunochromatographic Assay Testing Sales Volume-Based Market Share by Result Type (2021-2032)
Figure 38. Global Lateral Flow Immunochromatographic Assay Testing Revenue-Based Market Share by Result Type (2021-2032)
Figure 39. Global Lateral Flow Immunochromatographic Assay Testing ASP by Result Type (US$/Unit), 2021-2032
Figure 40. Global Lateral Flow Immunochromatographic Assay Testing Sales Market Share by Application (2021-2032)
Figure 41. Global Lateral Flow Immunochromatographic Assay Testing Revenue-Based Market Share by Application (2021-2032)
Figure 42. Global Lateral Flow Immunochromatographic Assay Testing ASP by Application (US$/Unit), 2021-2032
Figure 43. North America Lateral Flow Immunochromatographic Assay Testing Sales YoY (K Units), 2021-2032
Figure 44. North America Lateral Flow Immunochromatographic Assay Testing Revenue YoY (US$ Million), 2021-2032
Figure 45. North America Top 5 Manufacturers Lateral Flow Immunochromatographic Assay Testing Sales Revenue (US$ Million) in 2025
Figure 46. North America Lateral Flow Immunochromatographic Assay Testing Sales Volume (K Units) by Application (2021-2032)
Figure 47. North America Lateral Flow Immunochromatographic Assay Testing Sales Revenue (US$ Million) by Application (2021-2032)
Figure 48. US Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 49. Canada Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 50. Mexico Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 51. Europe Lateral Flow Immunochromatographic Assay Testing Sales YoY (K Units), 2021-2032
Figure 52. Europe Lateral Flow Immunochromatographic Assay Testing Revenue YoY (US$ Million), 2021-2032
Figure 53. Europe Top 5 Manufacturers Lateral Flow Immunochromatographic Assay Testing Sales Revenue (US$ Million) in 2025
Figure 54. Europe Lateral Flow Immunochromatographic Assay Testing Sales Volume (K Units) by Application (2021-2032)
Figure 55. Europe Lateral Flow Immunochromatographic Assay Testing Sales Revenue (US$ Million) by Application (2021-2032)
Figure 56. Germany Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 57. France Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 58. U.K. Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 59. Italy Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 60. Russia Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 61. Asia-Pacific Lateral Flow Immunochromatographic Assay Testing Sales YoY (K Units), 2021-2032
Figure 62. Asia-Pacific Lateral Flow Immunochromatographic Assay Testing Revenue YoY (US$ Million), 2021-2032
Figure 63. Asia-Pacific Top 8 Manufacturers Lateral Flow Immunochromatographic Assay Testing Sales Revenue (US$ Million) in 2025
Figure 64. Asia-Pacific Lateral Flow Immunochromatographic Assay Testing Sales Volume (K Units) by Application (2021-2032)
Figure 65. Asia-Pacific Lateral Flow Immunochromatographic Assay Testing Sales Revenue (US$ Million) by Application (2021-2032)
Figure 66. Indonesia Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 67. Japan Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 68. South Korea Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 69. China Taiwan Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 70. India Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 71. Central and South America Lateral Flow Immunochromatographic Assay Testing Sales YoY (K Units), 2021-2032
Figure 72. Central and South America Lateral Flow Immunochromatographic Assay Testing Revenue YoY (US$ Million), 2021-2032
Figure 73. Central and South America Top 5 Manufacturers Lateral Flow Immunochromatographic Assay Testing Sales Revenue (US$ Million) in 2025
Figure 74. Central and South America Lateral Flow Immunochromatographic Assay Testing Sales Volume (K Units) by Application (2021-2032)
Figure 75. Central and South America Lateral Flow Immunochromatographic Assay Testing Sales Revenue (US$ Million) by Application (2021-2032)
Figure 76. Brazil Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 77. Argentina Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 78. Middle East, and Africa Lateral Flow Immunochromatographic Assay Testing Sales YoY (K Units), 2021-2032
Figure 79. Middle East and Africa Lateral Flow Immunochromatographic Assay Testing Revenue YoY (US$ Million), 2021-2032
Figure 80. Middle East and Africa Top 5 Manufacturers Lateral Flow Immunochromatographic Assay Testing Sales Revenue (US$ Million) in 2025
Figure 81. Middle East and Africa Lateral Flow Immunochromatographic Assay Testing Sales Volume (K Units) by Application (2021-2032)
Figure 82. Middle East and Africa Lateral Flow Immunochromatographic Assay Testing Sales Revenue (US$ Million) by Application (2021-2032)
Figure 83. GCC Countries Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 84. Turkey Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 85. Egypt Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 86. South Africa Lateral Flow Immunochromatographic Assay Testing Revenue (US$ Million), 2021-2032
Figure 87. Lateral Flow Immunochromatographic Assay Testing Industry Chain Mapping
Figure 88. Regional Lateral Flow Immunochromatographic Assay Testing Manufacturing Base Distribution (%)
Figure 89. Global Lateral Flow Immunochromatographic Assay Testing Production Market Share by Region (2021-2032)
Figure 90. Lateral Flow Immunochromatographic Assay Testing Production Process
Figure 91. Regional Lateral Flow Immunochromatographic Assay Testing Production Cost Structure
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed